Literature DB >> 3375252

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

A R Fritzberg1, P G Abrams, P L Beaumier, S Kasina, A C Morgan, T N Rao, J M Reno, J A Sanderson, A Srinivasan, D S Wilbur.   

Abstract

Technetium-99m labeling of antibodies has been suboptimal because of low affinity adventitious binding, nonspecific labeling, and loss of immunoreactivity. The diamide dithiolate ligand system (N2S2) forms highly stable, well-defined tetradentate complexes with Tc(V). Antibodies and their fragments have been labeled by conjugation of preformed 99mTc-4,5-bis(thioacetamido)pentanoate active ester to protein amine groups to give a chemically known 99mTc-N2S2 complex covalently linked to antibody. Evaluations of the 99mTc-N2S2-bound antibodies and their fragments have shown high stability and retained immunoreactivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3375252      PMCID: PMC280353          DOI: 10.1073/pnas.85.11.4025

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.

Authors:  J A Carrasquillo; P G Abrams; R W Schroff; J C Reynolds; C S Woodhouse; A C Morgan; A M Keenan; K A Foon; P Perentesis; S Marshall
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

2.  Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

Authors:  D A Scheinberg; M Strand; O A Gansow
Journal:  Science       Date:  1982-03-19       Impact factor: 47.728

3.  Production and characterization of monoclonal antibody to a melanoma specific glycoprotein.

Authors:  A C Morgan; D R Galloway; R A Reisfeld
Journal:  Hybridoma       Date:  1981

4.  Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m.

Authors:  R L Childs; D J Hnatowich
Journal:  J Nucl Med       Date:  1985-03       Impact factor: 10.057

5.  Radioactive labeling of antibody: a simple and efficient method.

Authors:  D J Hnatowich; W W Layne; R L Childs; D Lanteigne; M A Davis; T W Griffin; P W Doherty
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

6.  Localization of tumours using radiolabelled antibodies.

Authors:  A R Bradwell; D S Fairweather; P W Dykes
Journal:  Med Lab Sci       Date:  1984-07

7.  Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.

Authors:  K Thielemans; D G Maloney; T Meeker; J Fujimoto; C Doss; R A Warnke; J Bindl; J Gralow; R A Miller; R Levy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.

Authors:  J A Carrasquillo; K A Krohn; P Beaumier; R W McGuffin; J P Brown; K E Hellström; I Hellström; S M Larson
Journal:  Cancer Treat Rep       Date:  1984-01

9.  The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS.

Authors:  C E Costello; J W Brodack; A G Jones; A Davison; D L Johnson; S Kasina; A R Fritzberg
Journal:  J Nucl Med       Date:  1983-04       Impact factor: 10.057

10.  Characterization of tin-technetium colloid in technetium-labeled albumin preparations.

Authors:  W A Petit; F H DeLand; G H Pepper; L Blanton
Journal:  J Nucl Med       Date:  1978-04       Impact factor: 10.057

View more
  10 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

Review 2.  Immunoscintigraphy for cancer detection: "a thousand ills require a thousand cures".

Authors:  S H de Bie; T C Ferreira; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 3.  Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Anticancer Agents Med Chem       Date:  2007-05       Impact factor: 2.505

Review 4.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

Review 5.  Radiopharmaceuticals: state of the art.

Authors:  A M Verbruggen
Journal:  Eur J Nucl Med       Date:  1990

6.  Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2.

Authors:  B M Mueller; R A Reisfeld; S D Gillies
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

Authors:  M F Giblin; N Wang; T J Hoffman; S S Jurisson; T P Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.

Authors:  Benjamin B Kasten; Xiaowei Ma; Kai Cheng; Lihong Bu; Winston S Slocumb; Thomas R Hayes; Steven Trabue; Zhen Cheng; Paul D Benny
Journal:  Bioconjug Chem       Date:  2015-12-30       Impact factor: 4.774

Review 9.  Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems.

Authors:  W C Eckelman
Journal:  Eur J Nucl Med       Date:  1995-03

Review 10.  The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.

Authors:  Timothy H Witney; Philip J Blower
Journal:  Cancer Imaging       Date:  2021-01-30       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.